Chronic Eosinophilic Leukemia-Not Otherwise Specified (CEL-NOS)
Idiopathic Hypereosinophilic Syndrome (IHES)

2018-06-01   Anwar N. Mohamed 

1.Cytogenetics Laboratory, Pathology Department, Detroit Medical Center, Wayne, State University School of Medicine, Detroit, MI USA;


; Chronic eosinophilic leukemia (CEL) not otherwise specified (NOS) and idiopathic hypereosinophilic syndrome (HES) are rare hematologic disorders characterized by chronic, unexplained eosinophilia with manifestation of organ involvement related to eosinophil infiltration, in the absence of evidence of secondary causes such as parasitic infestation, allergy, or neoplasm. Neither CEL-NOS nor idiopathic HES show Ph chromosome/ BCR-ABL fusion gene or other genetically defined entities such as PDGFRA, PDGFRB, or FGFR1 abnormalities.

Clinics and Pathology


Chronic Eosinophilic Leukemia not otherwise specified (CEL-NOS)
CEL-NOS is a myeloproliferative neoplasm caused by autonomous clonal proliferation of eosinophilic precursors that result to increased number of eosinophils in peripheral blood, bone marrow and peripheral tissues with eosinophilia being the most striking feature. The key criteria for diagnosis of CEL-NOS are peripheral blood hypereosinophilia (>1.5 -10 9/L), an increased number of myeloblasts in blood and bone marrow (<20%) or an evidence of eosinophil clonality (Bain et al, 2016; Gotlib, 2017). Clinically, it is necessary to rule out secondary causes of eosinophilia including allergy, parasite infestation, drug reaction, collagen-vascular disease, and neoplasms associated with reactive eosionophilia such as Hodgkin lymphoma, T cell lymphomas, and acute lymphoblastic leukemia (Tefferi et al, 2006). Moreover, the cases of myeloid and lymphoid neoplasms with eosinophilia and abnormalities of platelet-derived growth factor alpha ( PDGFRA), platelet-derived growth factor beta ( PDGFRB), and fibroblast growth factor receptor 1 ( FGFR1) must be also excluded (Gotlib and Cools, 2008; Gotlib, 2015).
The diagnostic criteria of CEL-NOS based on the revised WHO 2016 include:
1 Marked eosinophilia, count of ≥ 1.5x109/L in peripheral blood persisting for more than 6 months
2 An increase of myeloblasts in peripheral blood >2% or bone marrow myeloblasts < 20% of all nucleated cells
3 There is an evidence of clonality of eosinophils verified by detection of clonal cytogenetic or molecular genetic abnormality, or by demonstration of skewed expression of X chromosome genes
4 Does not meet the WHO diagnostic criteria for chronic myeloid leukemia (CML), or other myeloproliferative neoplasms ( PV, ET, PMF, systemic mastocytosis) or MDS/MPN ( CMML or atypical CML)
5 No t(9;22) BCR / ABL1 fusion; No rearrangement of PDGFRA, PDGFRB, or FGFR1; no PCM1 / JAK2, ETV6 /JAK2, or BCR/JAK2 fusion gene
6 No inv(16) / CBFB rearrangement and other diagnostic features of acute myeloid leukemia (AML).
Idiopathic hypereosinophilic syndrome (IHES)
If clonality of eosinophils cannot be proven and there is no increase in myleoblasts, then the diagnosis is idiopathic HES (Bain et al, 2016). Idiopathic HES is a diagnosis of exclusion when secondary and clonal causes of eosinophilia are ruled out (Bain, 2004 A; Bain, 2004B). It is defined as sustained eosinophilia ≥ 1.5X10 9 in peripheral blood for at least 6 months with signs of organ involvement and dysfunction in which the underlying cause remains unknown (Figure 1). There is no increase in blasts and no evidence of eosinophil clonalilty. Yet, the advances in molecular diagnostic technologies have demonstrated that many patients who had previously been considered as having idiopathic HES can now be found to have an eosinophilic leukemia since clonal molecular genetic abnormality can be demonstrated (Gotlib and Cools 2008). Moreover, transformation to acute myeloid leukemia in some patients with idiopathic HES also provides evidence that the disorder was likely from the start to be a clonal CEL (Wang et al, 2016).


The incidence of CEL-NOS is not well-defined due to rarity of the disorders and difficulty to distinguish CEL-NOS from idiopathic HES. Recently reported study using the Surveillance, Epidemiology, and End Results shows an incidence of 0.036 per 100,000 person-years, but this calculation included patients with HES and other clonal CEL (Crane et al, 2010). CEL-NOS affect more males than females with a reported median age of diagnosis in the sixty (Bain et al, 2016; Wang et al 2016). The epidemiology features of idiopathic HES remain undefined.


Patients may present with various combinations of symptoms and signs of end-organ damage mediated by eosinophils. In many patients, the onset of symptoms is insidious, and eosinophilia is detected incidentally. However in others, the initial manifestations are severe and life-threatening due to the rapid progression of cardiovascular or neurologic complications. The common constitutional symptoms that patients experience are fatigue, cough, dyspnea, myalgia, fever, diarrhea, rash and/or rhinitis. Progressive heart failure is an example of eosinophil-mediated organ injury which is the major cause of morbidity and mortality in these patients. Endocardial damage with resulting platelet thrombus can lead to mural thrombi and increased embolic risk. In the later fibrotic stage, endomyocardial fibrosis can evolve to a restrictive cardiomyopathy, and insufficiency of the mitral and tricuspid valves. Pulmonary disease affects up to 50% of those patients. Pulmonary infiltrates and fibrosis may develop focal or diffuse. Hematologic manifestations are largely nonspecific and may include fatigue, which may be due to the anemia. Thrombotic episodes due to cardiac injury or caused by hypercoagulability occur frequently and often present as neurologic symptoms. CNS dysfunction, peripheral neuropathy, GI disorders and skin lesions are also frequent manifestations (Gotlib 2015, Gotlib 2017).
Atlas Image


The most remarkable feature in the peripheral blood is hypereosinophilia usually greater than 1.5x10 9 /L. The leukocyte count is often moderately elevated between 20,000-30,000/μL, and eosinophils in most instances account for 30%-70% of the differential counts. The blood exhibits mature eosinophils with only a small number of eosinophilic myelocytes or promyelocytes. A range of eosinophil abnormalities may be seen such as sparse granulation, cytoplasmic vaculation, small or immature granules, nuclear hypersegmentation or hyposegmentation. Some patients may show monocytosis, mild basophillia or increased blasts. Anemia and thrombocytopenia may be present (Gotlib, 2017).
The bone marrow is usually hypercellular and shows eosinophilic hyperplasia. Eosinophil counts may range from 10% -70% of the bone marrow nucleated cells, with an average of 30%. The maturation of eosinophils and myeloid cells is progressive but often left-shifted with increased blasts (5%-19%). Charcot-Leyden crystals are frequently seen which are colorless crystals formed from the breakdown of eosinophils. Eosinophils may show dysplastic changes such as nuclear hypersegmentation or hyposegmentation, cytoplasmic vacuolization or hypogranularity, and/or abnormal eosinophilic granules. Still, these morphologic changes and Charcot-Leyden crystals are not specific for CEL since may be seen in reactive eosinophilia. Marrow fibrosis is seen in some cases (Bain et al, 2016). Eosinophilic infiltration may also be present in extramedullary tissues, most frequently involving skin, heart, lung, nervous system and gastrointestinal (GI) tract. Organ damage induced by eosinophilic infiltration is due to the release of eosinophil granules which contain toxic cationic proteins, the primary mediators of tissue damage. The site of infiltration usually shows some degree of fibrosis, often with the presence of Charcot-Leyden crystals.


Both CEL-NOS and idiopathic HES require the exclusion of the genetically defined eosinophilic neoplasms specifically cases with rearrangements of PDGFRA, PDGFRB, FGFR1, PCM1/JAK2 or variants [Figure 1]. In rare cases, the finding of Ph chromosome/BCR-ABL fusion indicates CML with dominant eosinophilia. No specific cytogenetic abnormality has been identified in CEL-NOS. Nevertheless, chromosomal abnormalities associated myeloid neoplasms such as trisomy chromosome 8, deletion of chromosome 7/7q, isochromosome 17q, and complex karyotype are frequently observed which indicate clonality and support the diagnosis of CEL-NOS. Humara test, X-linked polymorphism, has been used in female patients to demonstrate clonality.


Various agents are often used sequentially over the course of disease for treatment of CEL-NOS and idiopathic HES. Corticosteroid is the first-line therapy that induces remission in over 80% of patients. Hydroxyurea, and interferon alpha are also effective but are limited by their toxicity (Ogbogu et al, 2009). Alemtuzumab, an anti-CD52 monoclonal antibody, has been shown to control symptoms as well as eosinophilia in patients with refractory hypereosinophilic syndrome. Response to tyrosine kinase inhibitors, such as Imatinib is uncommon. High dose chemotherapy has been in used in some patients when disease showed progression. For those patients who fail the available pharmacologic therapies, stem cell transplant offers the potential for long-term remission and possible cure. In addition, patients may require interventions for specific cardiac complications, such as valve replacement, endomyocardectomy or thrombectomy. Evidence of hypersplenism and pain due to splenic infarction are indications for splenectomy (Gotlib, 2015).


CEL-NOS is a clinically aggressive disease, with a high rate transformation to acute leukemia, resistant to conventional therapy, and short survival. In a small series of 10 patients with CEL-NOS, the median survival time was little over 22 months with 50% of patients transformed to acute leukemia (Helbig et al 2012). Splenomegaly, increased blasts in bone marrow, cytogenetic abnormalities and dysplastic features of myeloid lineage are unfavorable prognostic findings. However, idiopathic HES is more heterogeneous and the median survival is longer than that of CEL-NOS (Wang et al, 2016). Features that signify a better prognosis include the absence of cardiac or neurologic involvement, lower eosinophil counts, and steroid-responsiveness.


Mutations in the JAK2, ASXL1, TET2, and EZH2 genes are frequently seen in CEL-NOS cases. Recently, Anderson and colleagues isolated eosinophils and performed next generation whole genome sequencing in five patients with idiopathic HES. Somatic missense mutations were found in three patients, including spliceosome gene PUF60 and the cadherin gene CDH17. In addition, they showed that aberrant DNA methylation patterns can distinguish clonal from reactive eosinophilia, which may be very useful in daily clinical work (Andersen et al, 2015). Other study used targeted next-generation sequencing panels designed for myeloid neoplasms to bone marrow specimens from a cohort of 51 idiopathic HES patients and 17 CEL-NOS patients (Wang et al, 2016). Mutations were detected in 14/51 (28%) of idiopathic HES involving single gene in 7 and ≥ 2 in the other 7 patients. Mutations frequently affected genes involving DNA methylation and chromatin modification. The more frequently mutated genes included ASXL1, TET2, EZH2, SETBP1, CBL, and NOTCH1. Mutations that characterize classic myeloproliferative neoplasms, including JAK2 V617F, MPL, and CALR, were all negative. KIT mutations were also not detected in any of their cases. The other 17 CEL-NOS showed multiple mutations, involving ASXL1, CSF3R, SETBP1, U2AF1, EZH2 and ETV6. However somatic mutations in genes such as TET2, JAK2, ASXL2, TP53 and others have been frequently found in elderly healthy individuals, therefore, these mutations should be interpreted with caution. Moreover, idiopathic HES patients with mutations, as a group, showed a number of clinical, laboratory and bone marrow findings resembling CEL-NOS. Wang and Colleagues concluded that targeted next-generation sequencing helps to establish clonality in a subset of patients with hypereosinophilia that would otherwise be classified as idiopathic hypereosinophilic syndrome (Wang et al 2016).

Highly cited references

Pubmed IDYearTitleCitations
357388042022Meaning of patient global assessment when joint counts are low in rheumatoid arthritis.0
357386722022Assessment of Heating on Titanium Alloy Cerebral Aneurysm Clips during 7T MRI.0
357386702022Spontaneous Spinal CSF Leaks Stratified by Age, Body Mass Index, and Spinal Level.0
357386002022To Fight or to Flee? A Systematic Review of Ectopic Pregnancy Management and Complications During the Covid-19 Pandemic.0
357383622022Online Crowdsourcing Survey of United States Population Preferences and Perceptions Regarding Outpatient Hip and Knee Arthroplasty.0
357381722022Widespread occurrence of emerging E-waste contaminants - Liquid crystal monomers in sediments of the Pearl River Estuary, China.0
357381482022Translation and reliability of the caregiver quality of life index-cancer (CQOLC) Scale in Hindi and it's association with the Kessler psychological distress scale (K10) for cancer caregivers at a tertiary radiotherapy centre in India.0
357381302022Impacts of slurry application methods and inhibitors on gaseous emissions and N2O pathways in meadow-cinnamon soil.0
357375912022Hospitalization and Emergency Department Encounters for COVID-19 After Paxlovid Treatment - California, December 2021-May 2022.0
357375392022Mapping the journey from epistemic mistrust in depressed adolescents receiving psychotherapy.0
357374612022Association of RASSF1A Ala133Ser polymorphism with cancer risk: a updated meta-analysis involving 7362 subjects.0
357373852022Adaptive Dynamic Therapy and Survivorship for Operable Pancreatic Cancer.0
357373552022Evaluation of the Fluorescence Polarization Assay for the Diagnosis of Brucellosis in Goat Milk.0
357372152022Automated methods for sella turcica segmentation on cephalometric radiographic data using deep learning (CNN) techniques.0
357372132022The Expression and Effect of ABCE1 in Gastric Adenocarcinoma.0
357371892022Effect of river-lake connectivity on ecological stoichiometry of lake and carbon storage status in Eastern Plain, China.0
357371632022Effects of Neonatal Administration of Non-Opiate Analogues of Leu-Enkephalin to Heart Tissue Homeostasis of Prepubertal Albino Rats Exposed to Hypoxia.0
357371082022COPP-MS: COrticosteroids during the Post-Partum in relapsing Multiple Sclerosis patients.0
357370102022Adjustable-loop implants are non-inferior to fixed-loop implants for femoral fixation in anterior cruciate ligament reconstruction.0
357369822022Compliance with Medication amongst Persons with Diabetes Mellitus during the COVID-19 Pandemic, Kerala, India: A Cross Sectional Study.0
357369502022Dynamics of the cerebral autoregulatory response to paced hyperventilation assessed using sub-component and time-varying analyses.0
357368702022What Findings on Chest CTs Can Delay Diagnosis of Pleuropulmonary Paragonimiasis?0
357368682022Effect of Androgen Deprivation Therapy on the Results of PET/CT with 18F-Fluciclovine in Patients with Metastatic Prostate Cancer.0
357367422022Endophytic Fungal and Bacterial Microbiota Shift in Rice and Barnyardgrass Grown under Co-Culture Condition.0
357367102022Molecular Assessment of Genetic Diversity and Genetic Structure of Rhanterium epapposum Oliv. in Scarce Populations in Some Regions of Western Saudi Arabia.0
357366242022Rehabilitation Program for Gait Training Using UAN.GO, a Powered Exoskeleton: A Case Report.0
357365212022Detection of unsuspected cathinone and piperazine-type drugs in urine samples positive for methamphetamine and amphetamine collected in emergency departments.0
357364852022Hypouricemic Effect of Submerged Culture of Ganoderma lucidum in Potassium Oxonate-Induced Hyperuricemic Rats.0
357363432022Characterization of Antimicrobial Composite Edible Film Formulated from Fermented Cheese Whey and Cassava Peel Starch.0
357360012022Comparative Bioavailability of a Single Dose of Trametinib (TMT212) Containing 9% vs 11% Dimethyl Sulfoxide in Randomized Healthy Volunteers to Assess Long-Term Storage at Room Temperature.0
357359412022Feasibility study of the prevalence of latent tuberculosis infection for Māori in the Waikato region, Aotearoa New Zealand.0
357359372022Immediate Tooth Autotransplantation with Root Canal Filling and Partially Demineralized Dentin/Cementum Matrix into Congenital Missing Tooth Region.0
357358572022Parasitism of Corn Earworm, Helicoverpa zea (Boddie) (Lepidoptera: Noctuidae), by Tachinid Flies in Cultivated Hemp.0
357358112022Efficacy and Safety of a Combined Aerobic, Strength and Flexibility Exercise Training Program in Patients with Implantable Cardiac Devices.0
357357312022Tuning Myogenesis by Controlling Gelatin Hydrogel Properties through Hydrogen Peroxide-Mediated Cross-Linking and Degradation.0
357357172022Identification of Gas Channeling and Construction of a Gel-Enhanced Foam Plugging System for Oxygen-Reduced Air Flooding in the Changqing Oilfield.0
357356952022Use of Betaine-Based Gel and Its Potential Application in Enhanced Oil Recovery.0
357356672022Further Validation of the Crohn's and Ulcerative Colitis Questionnaire-32 (CUCQ-32) to Measure the Quality of Life in Patients Treated with Biologics Therapy.0
357356552022Clinical and Radiographic Evaluation of a Novel Triangular Implant Neck Design: A Case Series.0
357356372022Assessment of Knowledge towards Radiation Protection Measures among Newly Graduated Dentists from Egypt and the Kingdom of Saudi Arabia: A Questionnaire-Based Cross-Sectional Study.0
357356272022Expression, Purification, and Characterisation of South African Cassava Mosaic Virus Cell-to-Cell Movement Protein.0
357355692022A High-Throughput MEMS-Based Differential Scanning Calorimeter for Direct Thermal Characterization of Antibodies.0
357355552022A Low-Cost Device for Measurement of Exhaled Breath for the Detection of Obstructive Lung Disease.0
357355452022Laser-Induced Graphene-Based Wearable Epidermal Ion-Selective Sensors for Noninvasive Multiplexed Sweat Analysis.0
357355412022Ensem-HAR: An Ensemble Deep Learning Model for Smartphone Sensor-Based Human Activity Recognition for Measurement of Elderly Health Monitoring.0
357352712022Impact of allograft types on outcomes after pediatric liver transplantation due to biliary atresia.0
357352112022Cardiac Morbidity and Mortality Associated with the Use of Lamotrigine.0
357352032022Immunophenotypic characteristics of ZNF384 rearrangement compared with BCR-ABL1, KMT2A rearrangement, and other adult B-cell precursor acute lymphoblastic leukemia.0
357352012022Multicenter Comparative Analysis of Late Open Conversion in Patients With Adherence and Nonadherence to Instructions for Use Endovascular Aneurysm Repair.0
357350472022Performance of PEDOTOH/PEO-based Supercapacitors in Agarose Gel Electrolyte.0
357348582022Safety and efficacy of long-term tofacitinib treatment in East Asian patients with ulcerative colitis in OCTAVE Open.0
357346922022Injuries associated with golf: A qualitative study.0
357345982022Effectiveness and Safety of Therapeutic Vaccines for Precancerous Cervical Lesions: A Systematic Review and Meta-Analysis.0
357343642022Serum Bile Acids in Intrahepatic Cholestasis of Pregnancy (ICP), Versus Pregnant and Nonpregnant Controls in Asian Indian Women and a Proposed Scoring to Optimize Management in ICP.0
357343502022Comparison of Slides and Video Clips as Different Methods for Inducing Emotions: An Electroencephalographic Alpha Modulation Study.0
357341262022Characterization of a fermented coconut milk product with and without strawberry pulp.0
357340842022Nirmatrelvir plus ritonavir for early COVID-19 and hospitalization in a large US health system.0
357340082022The impact of diabetes mellitus on pulmonary TB.0
357339762022Axillary intra-aortic balloon pump, biventricular assist device implantation and subsequent orthotopic heart transplantation in a patient with sickle cell trait.0
357339542022Evolutionary Divergence of Marinobacter Strains in Cryopeg Brines as Revealed by Pangenomics.0
357339412022Effect of Exercise on Breast Cancer: A Systematic Review and Meta-analysis of Animal Experiments.0
357339312022Acanthocytes Identified in Huntington's Disease.0
357338132022Cannabidiol Reduces Inflammatory Lung Damage After Meconium Aspiration in Newborn Piglets.0
357337652022The Reproductive Outcome of Women with Hypogonadotropic Hypogonadism in IVF.0
357337032022Protective effects of liquiritin on polycystic ovary syndrome through modulating ovarian granulosa cell proliferation and apoptosis via miR-206/PI3K/AKT pathway.0
357336932022A study of the mechanical properties of the NEPE binders by molecular dynamic simulations and experiments.0
357336082022Awareness of human papillomavirus and reported human papillomavirus vaccine uptake in a high-risk population.0
357333402022Duration of Gram-negative antibiotic therapy in patients with pneumonia prior to and after the implementation of MRSA nasal swabs, an antimicrobial stewardship tool.0
357332982022Evaluation of inter-observer variability regarding aortic and mitral valve findings on transesophageal echocardiograms ordered for suspected endocarditis.0
357332022022Bilateral upper extremity motor priming (BUMP) plus task-specific training for severe, chronic upper limb hemiparesis: study protocol for a randomized clinical trial.0
357331522022Bartha-K61 vaccine protects nursery pigs against challenge with novel european and asian strains of suid herpesvirus 1.0
357331162022The impact of the union of lesser trochanter fragments after intramedullary fixation of trochanteric femoral fractures: an X-ray based study.0
357330942022Should preoperative computed tomography be routine examination for cervicofacial space infections?0
357330862022Effects of lidocaine administration via the perforated outer cuff of a dual-cuff endotracheal tube and remifentanil administration on recovery from general anaesthesia for female patients undergoing thyroidectomy: a single centre, double-blind, randomised study.0
357329582022Larger sagittal inter-screw distance/tibial width ratio reduces delayed union or non-union after arthroscopic ankle arthrodesis.0
357328842022The effect of combined loading on the behavior of micropiled rafts installed with inclined condition.0
357328782022Effect of E-cadherin on Prognosis of Colorectal Cancer: A Meta-Analysis Update.0
357325942022Associations of vascular risk and amyloid burden with subsequent dementia.0
357325502022Macrophage PD-1 associates with neutrophilia and reduced bacterial killing in early cystic fibrosis airway disease.0
357324262022Reducing the use of sleep-inducing drugs during hospitalisation by a multi-faceted intervention: a pilot study.0
357323542022Demography, disorders and mortality of pet hamsters under primary veterinary care in the United Kingdom in 2016.0
357321822022Arthroscopic Caudal Cruciate Ligament Damage in Canine Stifles with Cranial Cruciate Ligament Disease.0
357321602022Porous polyvinyl alcohol/graphene oxide composite film for strain sensing and energy storage applications.0
357321382022Screening for low-tract genital infections in women with threatened preterm labour. Which role?0
357320322022Exploring the health impacts and inequalities of the new way of working: findings from a cross-sectional study.0
357318822022Cortical-subcortical structural connections support transcranial magnetic stimulation engagement of the amygdala.0
357318742022Phase separation of HRLP regulates flowering time in Arabidopsis.0
357316412022A Critical Assessment of the Quality of Reporting of Ethical Protections in Medical Papers Published in Turkey.0
357315912022Outcomes of incident patients treated with incremental haemodialysis as compared to standard haemodialysis and peritoneal dialysis.0
357315352022Effect of Laparoscopic Sleeve Gastrectomy vs Roux-en-Y Gastric Bypass on Weight Loss, Comorbidities, and Reflux at 10 Years in Adult Patients With Obesity: The SLEEVEPASS Randomized Clinical Trial.0
357315332022Assessment of Noninvasive Brain Stimulation Interventions for Negative Symptoms of Schizophrenia: A Systematic Review and Network Meta-analysis.0
357315132022Trends in Diet Quality and Cardiometabolic Risk Factors Among Korean Adults, 2007-2018.0
357313232022Efficacy of Miniscrew-Assisted Rapid Palatal Expansion (MARPE) in late adolescents and adults with the Dutch Maxillary Expansion Device: a prospective clinical cohort study.0
357313212022Ovulation induction and intrauterine insemination in women of advanced reproductive age: a systematic review of the literature.0
357312932022Healthcare consumption among subjects with otitis media undergoing middle ear surgery-analysis of cost drivers.0
357311212022Accuracy of power Doppler ultrasonography in the diagnosis and monitoring of idiopathic inflammatory myopathies.0
357310732022Efficacy of amoxicillin or amoxicillin and clavulanic acid in reducing infection rates after third molar surgery: a systematic review and meta-analysis.0
357308352022Self-reported diabetes and factors associated with it in the Brazilian adult population: National Health Survey, 2019.0
357306092022Reliability of Past Medical History in a Single Hospital Participating in Get With The Guidelines-Stroke Registry.0


Pubmed IDLast YearTitleAuthors
264978542015Whole-exome sequencing and genome-wide methylation analyses identify novel disease associated mutations and methylation patterns in idiopathic hypereosinophilic syndrome.Andersen CL et al
155488342004Eosinophilic leukemia and idiopathic hypereosinophilic syndrome are mutually exclusive diagnoses.Bain BJ et al
206390122010Incidence of myeloproliferative hypereosinophilic syndrome in the United States and an estimate of all hypereosinophilic syndrome incidence.Crane MM et al
290446762017World Health Organization-defined eosinophilic disorders: 2017 update on diagnosis, risk stratification, and management.Gotlib J et al
188432832008Five years since the discovery of FIP1L1-PDGFRA: what we have learned about the fusion and other molecularly defined eosinophilias.Gotlib J et al
224735872012Chronic eosinophilic leukemia-not otherwise specified has a poor prognosis with unresponsiveness to conventional treatment and high risk of acute transformation.Helbig G et al
199100292009Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy.Ogbogu PU et al
166816352006Eosinophilia: secondary, clonal and idiopathic.Tefferi A et al
271745852016Targeted next-generation sequencing identifies a subset of idiopathic hypereosinophilic syndrome with features similar to chronic eosinophilic leukemia, not otherwise specified.Wang SA et al


Anwar N. Mohamed

Chronic Eosinophilic Leukemia-Not Otherwise Specified (CEL-NOS)
Idiopathic Hypereosinophilic Syndrome (IHES)

Atlas Genet Cytogenet Oncol Haematol. 2018-06-01

Online version:

External Links